Skip to main content

Table 1

From: Comparing the efficacy of Truvada® and Kivexa® combination therapy in HAART-naive individuals with different viral loads

  TRUVADA     KIVEXA    
  All (mean 122,106) VL >100,000 (mean 263,684) VL 10–100,000 (mean 45, 772) VL <10,000 (mean 5243) All (mean 99,883) VL > 100,000 (mean 256,364) VL 10–100,000 (mean 48, 221) VL < 10,000 (mean 6214)
Number of patients 53 20 23 10 33 9 20 4
VL <50 at 3 months (%) 60 35 74 80 73 60 80 75
Vl < 50 at 4 months (%) 75 60 87 90 79 78 85 75
VL < 50 at 6 months (%) 83 80 91 90 91 89 90 100
VL < 1000 at 4 weeks (%) 67 45 83 70 70 22 85 100